Klaus Pfizenmaier - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Klaus Pfizenmaier

Showing results (91-100 of 95) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 95 results.

Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016

Essential protective role of tumor necrosis factor receptor 2 in neurodegenerationYun Dong, Roman Fischer, Petrus J W Naudé, et al.

Frontiers in Immunology|July 26, 2021

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic InflammationFabian Richter, Sarah K Williams, Katharina John, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.

Nature Immunology|January 26, 2023

Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNFKai Ling Liang, Juliette Roels, Marieke Lavaert, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018

Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing SarcomaPilar Puerto-Camacho, Ana Teresa Amaral, Salah-Eddine Lamhamedi-Cherradi, et al.

Pageof 10

Search research articles

Showing results (91-100 of 95) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 95 results.

Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016

Essential protective role of tumor necrosis factor receptor 2 in neurodegenerationYun Dong, Roman Fischer, Petrus J W Naudé, et al.

Frontiers in Immunology|July 26, 2021

The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic InflammationFabian Richter, Sarah K Williams, Katharina John, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2020

OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor ModelsMyriam Fabre, Cristina Ferrer, Saioa Domínguez-Hormaetxe, et al.

Nature Immunology|January 26, 2023

Intrathymic dendritic cell-biased precursors promote human T cell lineage specification through IRF8-driven transmembrane TNFKai Ling Liang, Juliette Roels, Marieke Lavaert, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018

Preclinical Efficacy of Endoglin-Targeting Antibody-Drug Conjugates for the Treatment of Ewing SarcomaPilar Puerto-Camacho, Ana Teresa Amaral, Salah-Eddine Lamhamedi-Cherradi, et al.

Pageof 10